Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin and Irinotecan vs Cisplatin and Etoposide in Extensive Stage Small Cell Lung Cancer
NCT00045162Phase 3Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Nov 2002
- Primary completion
- Mar 2008
- Modality
- Nanoparticles, Monoclonal Antibodies, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of irinotecan hydrochloride liposome injection (II) + temozolomide + bevacizumab in small cell lung cancer (SCLC), sponsored by SWOG Cancer Research Network. Started Nov 2002; status: completed.
02
Drugs
irinotecan hydrochloride liposome injection (II) + temozolomide + bevacizumab
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00045162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00045162.